Nakamichi, S., Seike, M., Miyanaga, A., Chiba, M., Zou, F., Takahashi, A., . . . Gemma, A. (2018). Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial–mesenchymal transition is critical in conquering ALK-positive lung cancer. Oncotarget.
Stile di citazione ChicagoNakamichi, Shinji, et al. "Overcoming Drug-tolerant Cancer Cell Subpopulations Showing AXL Activation and Epithelial–mesenchymal Transition Is Critical in Conquering ALK-positive Lung Cancer." Oncotarget 2018.
Citazione MLANakamichi, Shinji, et al. "Overcoming Drug-tolerant Cancer Cell Subpopulations Showing AXL Activation and Epithelial–mesenchymal Transition Is Critical in Conquering ALK-positive Lung Cancer." Oncotarget 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.